Join the club for FREE to access the whole archive and other member benefits.

Marc Ramis-Castelltort

Co-Founder and CEO at Senolytic Therapeutics and Rejuveron.

Marc is passionate about creating novel biomedical ventures. He is a co-founder at Rejuversen AG, Ninevah Therapeutics SL and Senolytic Therapeutics Inc. Currently, Marc is a Board member or strategic advisor at Ninevah Therapeutics, Retinset Therapeutics, Cyclomed, Gate2Brain, Cebiotex and Origen Ventures. He is a co-founder and Partner at Chasing Science, an early-stage biomedical venture builder.

Marc gained a DPhil in Biochemistry from the University of Oxford, a PDL executive degree at Harvard Business School, a M.Sc. in Chemical Engineering and a B.Sc. in Chemistry from IQS (Barcelona).

Visit website:



See also: Company Rejuveron - Company that develops and invests in drugs and technologies which prolong human lifespan.

Details last updated 17-Feb-2021

Marc Ramis-Castelltort is also referenced in the following:

Longevity Leaders World Congress 2021

04-May-2021 to 07-May-2021

The virtual event for leaders in longevity science, technology, business and finance organized by Longevity Leaders (LSX).

Marc Ramis-Castelltort News

Super summary of 3rd Annual Longevity Therapeutics Summit (LEAF) - 16-Feb-2021

More and more companies making greater and greater progress - 2021 could be an exciting year